AcroMeta Group Limited Announces S\$1 Million Share Subscription Agreement

Key Highlights

• Conditional Share Subscription Agreement: AcroMeta Group Limited has entered into a conditional subscription agreement dated 30 January 2026 with private investor Elisabet to raise S\$1,000,000 via the issuance of new ordinary shares.
• Issue Price: New shares will be issued at S\$0.06 per share or at a 10% discount to the average weighted price on the last trading day before completion, whichever is higher. The minimum issue price of S\$0.06 is a significant 151% premium over the market price of S\$0.0239 on 30 January 2026.
• Number of Shares Issued: Assuming S\$0.06 per share, 16,666,667 new ordinary shares will be allotted, representing approximately 4.28% of the current share capital and 4.10% of the enlarged share capital post-issue.
• Exemption from Prospectus Requirement: The subscription is made under Section 272B of the Securities and Futures Act (SFA), meaning no prospectus or offer information statement will be issued.
• No Change in Controlling Interest: The new shares will not be issued to directors, substantial shareholders, or related parties as defined under Rule 812(1) of the Catalist Rules. There will be no change in the company’s controlling interest.
• Share Mandate and Listing Application: Shares will be issued under the general share issue mandate granted at the January 2026 AGM. Application for listing and quotation of the new shares on SGX Catalist will be submitted via the company’s sponsor, W Capital Markets Pte. Ltd.

Details and Financial Impact

• Subscriber Profile: Elisabet is a private investor and a major shareholder of PT Esa Jaya Labdagati, but is not a director or substantial shareholder of AcroMeta Group Limited. She has no material business relationships with AcroMeta apart from a strategic partnership with AcroMeta Minerals Pte. Ltd.
• Conditions Precedent: Completion is subject to SGX-ST approval for listing, the share mandate being in force, compliance with all relevant regulations, and all representations and warranties remaining true at completion (target date by 31 May 2026).
• Financial Effects:
• Net Tangible Assets (NTA) per Share: Increases from S\$0.93 cents (before) to S\$1.14 cents (after) with the new capital injection.
• Loss Per Share (LPS): Improves from S\$1.11 cents (before) to S\$1.06 cents (after), attributed to the increase in share base.
• Purpose of Proceeds: Net proceeds of S\$980,000 (after expenses) will be used for general working capital, with potential for short-term investments until fully deployed.
• Other Recent Share Issues: 8,000,000 new shares were allotted on 30 January 2026 under the AcroMeta Performance Share Plan 2025, with listing on SGX-ST on 3 February 2026.
• Director’s Opinion: The board believes that the group’s current working capital is sufficient but aims to strengthen its position and fund future growth and expansion with the additional capital.
• Directors’ and Major Shareholders’ Interests: No director or substantial shareholder has any interest in the new share subscription outside their ordinary roles.
• Inspection of Agreement: The subscription agreement is available for inspection at the company’s registered office for three months from the announcement date.

Important Information for Shareholders

• Potential Price Sensitivity: The announcement of a share placement at a premium may signal confidence in the company and its prospects, potentially supporting the share price. However, shareholders should note the resulting dilution (new shares represent 4.10% of enlarged capital).
• Strategic Investor Entry: Elisabet’s involvement may hint at possible future collaborations, especially considering her links to PT Esa Jaya Labdagati and recent partnership with AcroMeta Minerals Pte. Ltd.
• Completion Risks: There is no assurance that the subscription will be completed or that all terms will remain unchanged. Shareholders are advised to monitor further announcements closely.

Trading Caution

Shareholders and potential investors should exercise caution when trading in AcroMeta Group Limited’s shares. The completion of the proposed subscription, as well as the terms, remain subject to regulatory approvals and satisfaction of conditions precedent. Investors should consult professional advisers if in doubt about their actions.

Conclusion

The S\$1 million share subscription agreement is a noteworthy development for AcroMeta Group Limited, potentially strengthening its working capital and supporting future growth. The premium pricing, strategic investor entry, and the lack of controlling interest change are factors that could influence investor sentiment and share price dynamics. However, completion risk and dilution should be considered.

Disclaimer: This article is for informational purposes only and does not constitute investment advice or a solicitation to buy or sell securities. Investors should conduct their own due diligence and consult their professional advisers before making any investment decisions. The information herein is based on public disclosures and may be subject to change. The Singapore Exchange Securities Trading Limited and the company’s sponsor have not examined or approved the contents of this article.

View AcroMeta Historical chart here